Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Cytokine
100%
Glucose Uptake
100%
Hexose
100%
Programmed Cell Death
66%
Protein Tyrosine Kinase
66%
Cell Surface
66%
Signal Transduction Pathway
66%
Imatinib
66%
Absence
66%
Protein Kinase B
66%
Cell Viability
33%
Phosphotransferase Inhibitor
33%
Phosphotransferase
33%
Cell Survival
33%
Oncoprotein
33%
Internalization
33%
Glucose Transporter 1
33%
Phosphoinositide 3-Kinase Inhibitor
33%
Abelson Kinase
33%
Cell Line
33%
Combination Therapy
33%
Hematopoietic Stem Cell
33%
Biochemistry, Genetics and Molecular Biology
Glucose Transport
100%
Hexose
100%
Myeloid
100%
Cytokine
100%
Signal Transduction
66%
Surface Property
66%
Tyrosine Kinase
66%
Phosphotransferase
66%
Kinase
66%
Receptor Tyrosine Kinase
66%
Protein Kinase B
66%
GLUT1
33%
Glucose Transporter
33%
Hematopoietic Stem Cell
33%
Cell Survival
33%
Internalization
33%
Cell Viability
33%
Phosphoinositide 3-Kinase Inhibitor
33%
Maximum Reaction Velocity
33%
Neuroscience
Myeloid
100%
Glucose Transport
100%
Hexose
100%
Receptor Tyrosine Kinase
66%
Protein Kinase B
66%
Signal Transduction Pathway
66%
Epileptic Absence
66%
Tyrosine Kinase
66%
Imatinib
66%
Kinase
33%
Cell Line
33%
Cell Survival
33%
Internalization
33%
Hematopoietic Stem Cell
33%
Cell Viability
33%
Abelson Kinase
33%
Oncoprotein
33%
Phosphoinositide 3-Kinase Inhibitor
33%
Glucose Transporter 1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Chronic Myeloid Leukemia
100%
Hexose
100%
Epileptic Absence
66%
Protein Tyrosine Kinase
66%
Imatinib
66%
Protein Kinase B
66%
Cell Viability
33%
Combination Therapy
33%
Phosphotransferase Inhibitor
33%
Phosphotransferase
33%
Oncoprotein
33%
Glucose Transporter 1
33%
Phosphatidylinositol 3 Kinase Inhibitor
33%
Abelson Kinase
33%
Immunology and Microbiology
Myeloid
100%
Cytokine
100%
Glucose Transport
100%
Cell Surface
66%
Signal Transduction
66%
Hematopoietic Stem Cell
33%
Cell Line
33%
Internalization
33%
Cell Viability
33%
Cell Survival
33%
Glucose Transporter
33%
Maximum Reaction Velocity
33%